NEW YORK CITY, NY / ACCESS Newswire / March 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

NEW YORK CITY, NY / ACCESS Newswire / March 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

From a historic vaccine approval to a $50bn investment reshaping US drug manufacturing, February brought major pharma news to ...

Pomerantz LLP is investigating claims on behalf of investors of Valneva SE ("Valneva" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ...

Management will discuss Valneva’s pipeline of potential first-in-class vaccine candidates, including its lead Lyme disease vaccine, VLA15, and its Shigella and Zika programs alongside the Company’s ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The vaccine, manufactured by the biotechnology company Valneva, was the first vaccine approved by the US Food and Drug Administration to prevent disease caused by chikungunya virus. The approval ...

Met 2024 growth targets for sales revenue (+13% vs 2023) and total revenues (+10% vs 2023)Strong year-end cash position of €168.3 millionSubstantial clinical and regulatory progress in 2024 ...

Valneva SE (NASDAQ:VALN – Free Report) – Stock analysts at HC Wainwright lowered their Q4 2024 EPS estimates for shares of Valneva in a report issued on Wednesday, February 19th.HC Wainwright ...

Hedge funds and other institutional investors own 11.39% of the company’s stock. Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for ...

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes two vaccines for travelers; one for the prevention of Japanese encephalitis (IXIARO) and the second ...

Investing.com – U.S. stocks were mixed after the close on Monday, as gains in the Oil & Gas, Financials and Telecoms sectors led shares higher while losses in the Healthcare, ...